Comparative Metabolomics of Marine Bivalves Identifies Key Mitochondrial and Amino Acid Signatures of Extreme Longevity

A comparative metabolomic analysis of five bivalve species with lifespans up to 507 years reveals that extreme longevity is characterized by structural remodeling of mitochondrial and amino acid pathways, suggesting a conserved metabolic architecture prioritizing long-term cellular maintenance.

Researchers conducted targeted metabolomic profiling in gill and mantle tissues across five marine bivalve species representing a wide lifespan gradient: Mya arenaria (maximum reported longevity of 28 years), Spisula solidissima (37 years), Mactromeris polynyma (92 years), Mercenaria mercenaria (106 years), and the exceptionally long-lived ocean quahog, Arctica islandica (507 years).

The study quantified 50 key metabolites associated with central bioenergetic pathways, including the tricarboxylic acid (TCA) cycle, glycolysis, and amino acid metabolism.

The findings, published in Aging Cell, show that longevity is a dominant driver of metabolomic variation across these species, characterized by a global reduction in free amino acid pools, reduced baseline levels of lactate, and coordinated shifts in key TCA cycle intermediates—specifically increased succinate-to-fumarate ratios alongside decreased malate and fumarate concentrations.

The results suggest that extreme longevity does not stem from a simple, generalized suppression of metabolic rates, but rather from a highly refined allocation of metabolic resources toward homeostatic maintenance and redox stability.

The observed shift in the succinate-to-fumarate ratio suggests functional alterations in electron transport system (ETS) complexes. Limiting forward or reverse electron flux at these specific nodes may protect tissues from excessive reactive oxygen species (ROS) generation, particularly during hypoxia-reoxygenation challenges.

Coordinated reductions in branched-chain amino acids (BCAAs) and methionine in long-lived bivalves mirror established longevity-associated metabolic signatures in mammals, supporting the existence of deeply conserved evolutionary links between nutrient sensing, mitochondrial efficiency, and lifespan.

These findings validate the therapeutic rationale for biotechnology companies targeting mitochondrial metabolism and cellular stress responses, confirming that structural modifications in these pathways are naturally selected in exceptionally long-lived organisms.

The study provides solid evolutionary evidence supporting the focus of longevity medicine developers on downstream endpoints of nutrient sensing, such as the modulation of amino acid economics and mitochondrial quality preservation.

Translational studies attempting to assess if therapeutic interventions targeting the succinate-fumarate regulatory node can replicate these protective metabolic profiles in mammalian models.

Further comparative research validating whether these distinct metabolic signatures directly correlate with the phenotypic capacity of long-lived species to tolerate extreme environmental stressors such as prolonged hypoxia and reoxygenation.